Montreal, Canada

Karunakar Reddy Bonepally

This inventor holds 1 USPTO granted patent. Top assignee: Sail Biomedicines. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karunakar Reddy Bonepally. Retrieved from https://idiyas.com/inventor/karunakar-reddy-bonepally

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Karunakar Reddy Bonepally and His Patent Work

Introduction

Karunakar Reddy Bonepally is an inventor based in Montreal, Canada. He is associated with Sail Biomedicines and is named on 1 patent.

Latest Patents

His patent, “Pyridopyrimidinone Derivatives as AHR Antagonists,” concerns compounds of formula (Ia), their pharmaceutically acceptable salts, and pharmaceutical compositions containing them. The disclosure also covers methods of preparing the compounds, useful intermediate compounds, and potential treatments or preventive approaches for diseases associated with aberrant AHR signaling. These include cancer and conditions involving dysregulated immune responses. The compounds may also be used in cancer treatment alongside at least one additional therapy.

Career Highlights

Bonepally’s listed patent work focuses on AHR antagonists and their potential therapeutic applications. His association with Sail Biomedicines connects this work to a company engaged in biotechnology innovation.

Collaborations

The supplied information identifies Alessandra Bartolozzi and John Robert Proudfoot as Bonepally’s coworkers. The patent disclosure describes research relevant to developing potential therapies for cancer and immune-related conditions.

Conclusion

Karunakar Reddy Bonepally’s patent contribution centers on pyridopyrimidinone derivatives that may offer therapeutic applications through the modulation of AHR signaling.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…